trial
as of 2026-07-01Melatonin for Prevention of Metabolic Side Effects of Olanzapine
NCTId NCT01593774
at a glance
Phase 2 · Completed
Enrollment 36 (actual)
Sponsored by Guilan University of Medical Sciences
Primary completion 2013-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2012-05
Primary completion
2013-03
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Guilan University of Medical SciencesLead Sponsor
Investigators
1
Mohammad Jafar Modabbernia, MDStudy Chair
Sites
1 total
Rasht, Iran
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
36
Phase
PHASE2
Primary Completion Date
2013-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator